Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
- Véronique Diéras
- , Hyo S. Han
- , Bella Kaufman
- , Hans Wildiers
- , Michael Friedlander
- , Jean Pierre Ayoub
- , Shannon L. Puhalla
- , Igor Bondarenko
- , Mario Campone
- , Erik H. Jakobsen
- , Mathilde Jalving
- , Cristina Oprean
- , Marketa Palácová
- , Yeon Hee Park
- , Yaroslav Shparyk
- , Eduardo Yañez
- , Nikhil Khandelwal
- , Madan G. Kundu
- , Matthew Dudley
- , Christine K. Ratajczak
- Institut Curie
- Centre Georges-François Leclerc
- Moffitt Cancer Center
- Tel Aviv University
- KU Leuven
- University of New South Wales
- Centre Hospitalier de L'Universite de Montreal
- University of Pittsburgh
- Zaporizhia Medical Academy of Post-Gradate Education Ministry of Health of Ukraine
- Institut de Cancérologie de l'Ouest
- University of Southern Denmark
- University of Groningen
- Victor Babes University of Medicine and Pharmacy
- Masaryk Memorial Cancer Institute
- Lviv State Regional Treatment and Diagnostic Oncology Center
- Universidad de la Frontera
- AbbVie
- University of Texas MD Anderson Cancer Center
Research output: Contribution to journal › Article › peer-review
281
Link opens in a new tab
Scopus
citations